SYRE
Price
$22.63
Change
-$0.80 (-3.41%)
Updated
Nov 13 closing price
Capitalization
1.76B
104 days until earnings call
Intraday BUY SELL Signals
TERN
Price
$20.73
Change
+$0.43 (+2.12%)
Updated
Nov 13 closing price
Capitalization
1.87B
137 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SYRE vs TERN

Header iconSYRE vs TERN Comparison
Open Charts SYRE vs TERNBanner chart's image
Spyre Therapeutics
Price$22.63
Change-$0.80 (-3.41%)
Volume$514.56K
Capitalization1.76B
Terns Pharmaceuticals
Price$20.73
Change+$0.43 (+2.12%)
Volume$2.62M
Capitalization1.87B
SYRE vs TERN Comparison Chart in %
SYRE
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SYRE vs. TERN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Buy and TERN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (SYRE: $23.43 vs. TERN: $20.30)
Brand notoriety: SYRE and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 64% vs. TERN: 98%
Market capitalization -- SYRE: $1.76B vs. TERN: $1.87B
SYRE [@Biotechnology] is valued at $1.76B. TERN’s [@Biotechnology] market capitalization is $1.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, TERN is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 5 TA indicator(s) are bullish while TERN’s TA Score has 5 bullish TA indicator(s).

  • SYRE’s TA Score: 5 bullish, 5 bearish.
  • TERN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TERN is a better buy in the short-term than SYRE.

Price Growth

SYRE (@Biotechnology) experienced а +2.54% price change this week, while TERN (@Biotechnology) price change was +11.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

SYRE is expected to report earnings on Feb 26, 2026.

TERN is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($1.87B) has a higher market cap than SYRE($1.76B). TERN YTD gains are higher at: 266.426 vs. SYRE (0.644). TERN has higher annual earnings (EBITDA): -105M vs. SYRE (-222.15M). SYRE has more cash in the bank: 527M vs. TERN (315M). SYRE has less debt than TERN: SYRE (0) vs TERN (1.13M). SYRE (0) and TERN (0) have equivalent revenues.
SYRETERNSYRE / TERN
Capitalization1.76B1.87B94%
EBITDA-222.15M-105M212%
Gain YTD0.644266.4260%
P/E Ratio1.72N/A-
Revenue00-
Total Cash527M315M167%
Total Debt01.13M-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYRETERN
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
SYRE
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSPFX5.860.10
+1.74%
US Global Investors Global Res
EPSYX25.910.17
+0.66%
NYLI Epoch Global Equity Yield Class I
RTDRX17.620.02
+0.11%
Russell Inv Multifactor US Equity R6
SAIFX42.840.04
+0.09%
ClearBridge Large Cap Value I
EQPGX27.11N/A
N/A
Fidelity Advisor Equity Growth I

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with APGE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+0.34%
APGE - SYRE
59%
Loosely correlated
+0.24%
CGON - SYRE
58%
Loosely correlated
+1.47%
IDYA - SYRE
57%
Loosely correlated
-0.19%
RGNX - SYRE
56%
Loosely correlated
+0.43%
NRIX - SYRE
56%
Loosely correlated
-5.37%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with ELVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
-1.36%
ELVN - TERN
42%
Loosely correlated
+3.36%
MLTX - TERN
40%
Loosely correlated
+8.68%
STOK - TERN
40%
Loosely correlated
+0.08%
SYRE - TERN
39%
Loosely correlated
+0.34%
IDYA - TERN
37%
Loosely correlated
-0.19%
More